Clinical trials
Active, not recruiting trials in the Philippines
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
88 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2015 | 2 |
| 2018 | 5 |
| 2019 | 7 |
| 2020 | 4 |
| 2021 | 14 |
| 2022 | 13 |
| 2023 | 24 |
| 2024 | 10 |
| 2025 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 88 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 22 |
| Merck Sharp & Dohme LLC | 9 |
| Hoffmann-La Roche | 5 |
| Janssen Research & Development, LLC | 4 |
| Novartis Pharmaceuticals | 4 |
| Amgen | 3 |
| Biogen | 2 |
| Société des Produits Nestlé (SPN) | 2 |
| Viatris Innovation GmbH | 2 |
| AbbVie | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 12 |
| Breast Neoplasms | 7 |
| Lupus Erythematosus, Systemic | 7 |
| Neoplasm Metastasis | 6 |
| Carcinoma | 5 |
| Urinary Bladder Neoplasms | 4 |
| Autoimmune Diseases | 3 |
| Connective Tissue Diseases | 3 |
| Immune System Diseases | 3 |
| Lupus Erythematosus, Cutaneous | 3 |
Trials
Showing 76 to 88 of 88. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.